A 32-year-old male presents to the metabolic disorders clinic with recurrent episodes of severe hypoglycemia despite frequent meals. His parents report developmental delay and failure to thrive since infancy. Laboratory investigations reveal elevated lactate (8.2 mmol/L, normal <2), elevated pyruvate (0.35 mmol/L, normal <0.1), and normal liver function tests. Genetic testing confirms a homozygous mutation in the LDHA gene encoding lactate dehydrogenase. During an oral glucose tolerance test, his blood glucose rises appropriately, but lactate production remains disproportionately elevated. A colleague suggests that the mutation reduces the enzyme's affinity for its substrate (pyruvate) without significantly altering V_max. Which of the following best explains the biochemical consequence of this mutation on lactate dehydrogenase kinetics?

Explanation

## Understanding Michaelis-Menten Kinetics: K_m and Enzyme Affinity ### The K_m Parameter **Key Point:** K_m (Michaelis constant) is the substrate concentration at which an enzyme operates at half its maximum velocity (V_max/2). It is an **inverse measure of enzyme-substrate affinity** — a **higher K_m indicates lower affinity**, meaning the enzyme binds substrate less tightly and requires more substrate to achieve the same reaction rate. ### Analysis of the Mutation The question states the mutation **reduces affinity for pyruvate** without altering V_max. In Michaelis-Menten terms: - Reduced affinity → **increased K_m** - Unchanged V_max → same maximum catalytic capacity at saturating substrate ### Kinetic Consequences Using the Michaelis-Menten equation: $$v = \frac{V_{max} \cdot [S]}{K_m + [S]}$$ When K_m increases (with V_max unchanged): 1. At physiological pyruvate concentrations (~0.05–0.1 mmol/L), the denominator (K_m + [S]) becomes disproportionately larger 2. The reaction velocity (v) decreases significantly 3. The enzyme now requires a **higher substrate concentration** to reach half-maximal velocity This is the hallmark of a **competitive-like affinity reduction** — the enzyme's catalytic machinery is intact (V_max preserved), but it cannot efficiently bind substrate at normal physiological concentrations. ### Why the Other Options Are Wrong - **Option A (K_m decreases):** A decrease in K_m would indicate *increased* affinity — the opposite of what the mutation causes. - **Option B (substrate-independent constant velocity):** No enzyme operates independently of substrate concentration under Michaelis-Menten kinetics; velocity always depends on [S] relative to K_m. - **Option C (V_max decreases):** The question explicitly states V_max is not significantly altered; a reduced V_max would indicate fewer functional enzyme molecules or impaired catalytic rate constant (k_cat), not reduced affinity. ### Clinical Note **Clinical Pearl:** While the vignette describes a metabolic scenario, the core biochemical principle tested is straightforward: a mutation reducing substrate affinity raises K_m without changing V_max. This results in impaired enzyme efficiency at physiological (sub-saturating) substrate concentrations. This concept is high-yield for understanding how enzyme mutations cause metabolic disease — reduced affinity mutations manifest as inefficiency at normal substrate levels, whereas V_max mutations reduce maximum throughput regardless of substrate availability. **High-Yield (Harper's Illustrated Biochemistry / Lehninger Principles):** K_m reflects affinity; V_max reflects catalytic capacity. These are independent parameters in Michaelis-Menten kinetics. | Parameter | Normal LDH | Mutant LDH | |-----------|-----------|------------| | K_m | ~0.15 mmol/L | Increased (e.g., 0.5 mmol/L) | | V_max | Normal | Normal (unchanged) | | Velocity at [S] = 0.1 mmol/L | ~40% V_max | ~17% V_max | | Physiological consequence | Efficient substrate conversion | Impaired conversion at physiological [S] | **Mnemonic:** **KAFF** — K_m increases → Affinity Falls → more substrate needed → Function compromised at physiological concentrations.